pepmg_

Study summary · research use only

Immunomodulatory vasoactive intestinal peptide amphiphile micelles

Study · human · Biomaterials science · 2018 · DOI 10.1039/c8bm00466h · PMID 29896593

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

This study (species not specified) formulated two different vasoactive intestinal peptide (VIP) amphiphiles that form micelles of varying shapes. The authors report that VIP micelle structure was found to directly correlate with anti-inflammatory behavior, which they describe as evidence that these biomaterials could serve as a new therapeutic modality.

Abstract

Two different vasoactive intestinal peptide (VIP) amphiphiles have been formulated which readily form micelles of varying shapes. Interestingly, VIP micelle structure has been found to directly correlate to anti-inflammatory behavior providing evidence that these biomaterials can serve as a promising new therapeutic modality.

Read the full study on PubMed ↗

pepmg summarizes the peer-reviewed literature and links to every source. It sells nothing and ships nothing. Where an FDA label, a peer-reviewed study or a clinical-trial registry entry (labeled trial registry, not peer-reviewed) has published a dose, pepmg reports it with the source named; it gives no personalized recommendations and no administration technique. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.